News
We worked with slices of human hearts affected by HFpEF, a method developed in my lab at Baylor, integrating the findings with the results from studies in mouse and rat models of the condition to ...
Beyond the heart, the study hints that other transplantable organs could benefit from improved cold storage methods using a simple diuretic.
Results from MUSIC-HFpEF Phase 1/2a clinical trial show favorable safety profile and early clinical benefits with SRD-002 ...
Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases, but has limited disease-modifying therapeutics. SRD-002 is a gene therapy utilizing an ...
LONDON — The benefit of mineralocorticoid receptor antagonists (MRAs) for the treatment of patients with heart failure and mildly reduced or preserved ejection fraction has finally been ...
An international team of researchers has discovered a natural mechanism that protects the heart from heart failure with preserved ejection ... We worked with slices of human hearts affected ...
A natural mechanism that protects against heart failure with preserved ejection fraction (HFpEF) has been identified. When this mechanism fails, it leads to HFpEF development. Restoring it can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results